Our previous studies show that the combination of both diseases increases CRP, calprotectin and angiopoietin-like 8 levels, DNA damage, and chromosomal aberrations compared to patients with either psoriasis or a metabolic syndrome alone. The gene discussed is CRP; the disease is metabolic syndrome.